Cargando…

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling

SOX9 inactivation is frequent in colorectal cancer (CRC) due to SOX9 gene mutations and/or to ectopic expression of MiniSOX9, a dominant negative inhibitor of SOX9. In the present study, we report a heterozygous L142P inactivating mutation of SOX9 in the DLD-1 CRC cell line and we demonstrate that t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prévostel, Corinne, Rammah-Bouazza, Cyrine, Trauchessec, Hélène, Canterel-Thouennon, Lucile, Busson, Muriel, Ychou, Marc, Blache, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347687/ https://www.ncbi.nlm.nih.gov/pubmed/27429045 http://dx.doi.org/10.18632/oncotarget.10573

Ejemplares similares

Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer
por: Dupasquier, Sébastien, et al.
Publicado: (2019)

A Cell Model Suitable for a High-Throughput Screening of Inhibitors of the Wnt/β-Catenin Pathway
por: Grimaldi, Marina, et al.
Publicado: (2018)

Telomerase Protects Werner Syndrome Lineage-Specific Stem Cells from Premature Aging
por: Cheung, Hoi-Hung, et al.
Publicado: (2014)

Antibody targeting of claudin-1 as a potential colorectal cancer therapy
por: Cherradi, S., et al.
Publicado: (2017)

A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer
por: Grosgeorges, Marie, et al.
Publicado: (2023)

Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
por: Jeitany, Maya, et al.
Publicado: (2018)

Oncogenic activity of SOX1 in glioblastoma
por: Garcia, Idoia, et al.
Publicado: (2017)

Evidence That SOX2 Overexpression Is Oncogenic in the Lung
por: Lu, Yun, et al.
Publicado: (2010)

Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway
por: Liu, Huidi, et al.
Publicado: (2014)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

Targets of Wnt/ß-Catenin Transcription in Penile Carcinoma
por: Arya, Manit, et al.
Publicado: (2015)

SOX17 is a tumor suppressor in endometrial cancer
por: Zhang, Yongli, et al.
Publicado: (2016)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

Plakoglobin restores tumor suppressor activity of p53(R175H) mutant by sequestering the oncogenic potential of β‐catenin
por: Alaee, Mahsa, et al.
Publicado: (2018)

SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway
por: Tong, Xin, et al.
Publicado: (2014)

Constitutive ß-Catenin Signaling by the Viral Chemokine Receptor US28
por: Langemeijer, Ellen V., et al.
Publicado: (2012)

LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis
por: Yu, Eun-Jeong, et al.
Publicado: (2017)

The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß‐catenin signaling
por: Krug, Sebastian, et al.
Publicado: (2021)

Evolution and loss of ß-catenin and TCF-dependent axis specification in insects
por: Schmidt-Ott, Urs, et al.
Publicado: (2022)

Differentiation of Human Wharton's Jelly Mesenchymal Stem Cells into SOX17 Expressing Cells Using a Wnt/ß-catenin Pathway Agonist on Polylactic Acid/Chitosan Nanocomposite Scaffold
por: Hoveizi, Elham, et al.
Publicado: (2022)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
por: Stolzenburg, Sabine, et al.
Publicado: (2012)

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2019)

Targeting oncogenic SOX2 in human cancer cells: therapeutic application
por: Zhang, Shizhen, et al.
Publicado: (2019)

Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer
por: Jeusset, Lucile M-P., et al.
Publicado: (2017)

WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling
por: James, Richard G., et al.
Publicado: (2012)

Wnt/ß-Catenin: A New Therapeutic Approach to Acute Myeloid Leukemia
por: Kim, Y., et al.
Publicado: (2011)

Heterogeneous sensitivity of human Acute Myeloid Leukemia to ß-catenin down-modulation
por: Gandillet, Arnaud, et al.
Publicado: (2011)

Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer
por: Hong, Soon Auck, et al.
Publicado: (2018)

A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer
por: Sun, Jie, et al.
Publicado: (2021)

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
por: Lechner, J F, et al.
Publicado: (1997)

Genetic Basis for Carcinogenesis. Tumor Suppressor Genes and Oncogenes
por: Rabbitts, P.
Publicado: (1992)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Identification and analysis of mutational hotspots in oncogenes and tumour suppressors
por: Baeissa, Hanadi, et al.
Publicado: (2017)

Tumor Suppressors Having Oncogenic Functions: The Double Agents
por: Datta, Neerajana, et al.
Publicado: (2020)

Somatic selection distinguishes oncogenes and tumor suppressor genes
por: Chandrashekar, Pramod, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ag3o749fnjd42ds8bl2ph7igse